Mike Evers, Author at ORTHOWORLD

Medtronic Claims Knockout Victory in Spine

The company's orthopedic sales grew in the mid-single-digits for calendar year 2024 as its enabling technology disrupts market dynamics.

Feb 20, 2025

The acquisition of Paragon 28 moves Zimmer Biomet closer to its goals of MSD growth and category leadership in fast-growing segments.

Feb 17, 2025

The company grew 3.8% in 2024 driven by better operational performance and strategic efforts to enter higher-growth markets.

Feb 10, 2025

The company's orthopedic sales grew below-market at 2% in 2024 as it worked through significant supply chain challenges.

Feb 07, 2025

We look ahead and discuss three trends that could impact the landscape of the joint replacement market in 2025 and beyond.

Feb 06, 2025

Stryker divested the majority of its spinal implant business while Zimmer Biomet agreed to acquire foot-and-ankle player Paragon 28.

Jan 30, 2025

The company's orthopedic sales grew in the high single digits in 2024, driven by new products and healthy procedure demand.

Jan 30, 2025

The company's orthopedic business grew in the low-single-digits in 2024 as it faced restructuring and competitive headwinds.

Jan 24, 2025

In this video, we take a look at three things we might learn during company earnings reports for the fourth quarter of 2024.

Jan 20, 2025

The top four players in spine are fully invested in enabling technology and are changing the competitive dynamics of the segment.

Jan 15, 2025